YOU ARE HERE:
Resistance news
page  of 10
 
Headline
Date
  HIV transmission rate in US has declined enormously
16.12.08
  Widespread resistance to antiretrovirals among children in the Central African Republic
03.12.08
  Raltegravir may have role in PEP if exposure involves drug-resistant HIV
20.11.08
  Non-nucleoside resistance is efficiently transmitted within infection ‘clusters’
13.11.08
  South African resistance survey confirms that clade C is more likely to develop multi-drug resistance mutation
12.11.08
  Kivexa downgraded to alternative status in revised US HIV treatment guidelines
05.11.08
  Raltegravir resistance patterns becoming clearer
28.10.08
  Resistance to darunavir related to pre-existing mutations
06.10.08
  Higher levels of drug resistance seen after first-line NNRTI failure than boosted PI failure: meta-analysis
03.10.08
  Cluster of multi-drug resistant HIV transmissions in Seattle
30.09.08
  Widespread NRTI and NNRTI resistance seen in Malawian patients failing first-line antiretroviral therapy
06.08.08
  Low level of drug-resistant strains common in untreated patients, but may not affect treatment
22.07.08
  Untreated HIV infection may facilitate rifampicin-resistant and multi-drug-resistant TB strains
27.06.08
  Boosted protease inhibitors have 60% lower risk of resistance compared with other classes
18.06.08
  High death rates in Peruvian patients defaulting from multi-drug-resistant tuberculosis treatment
12.06.08
  Extensive resistance common in Nigerians failing antiretroviral therapy
05.06.08
  Most viral load blips are short-lasting and of no significance
19.05.08
  Nearly all patients with NNRTI resistance could benefit from etravirine, UK analysis shows
09.05.08
  Planned interruption of highly active antiretroviral therapy does not select drug resistance mutations in HIV-1-infected children
07.05.08
  Dual class drug resistance present in two-thirds of South African HIV cohort on failing ART
05.05.08

page  of 10